| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J7120 |
Ringers lactate infusion, up to 1000 cc |
283 |
233 |
$205K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
827 |
776 |
$59K |
| 36415 |
Collection of venous blood by venipuncture |
261 |
213 |
$55K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
217 |
208 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,835 |
236 |
$26K |
| A9270 |
Non-covered item or service |
2,550 |
493 |
$20K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
82 |
81 |
$12K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
237 |
214 |
$12K |
| 87486 |
|
14 |
13 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
135 |
132 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
350 |
61 |
$3K |
| 80053 |
Comprehensive metabolic panel |
143 |
126 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
46 |
44 |
$2K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
104 |
37 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
60 |
13 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
269 |
143 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
13 |
$1K |
| 85018 |
|
163 |
158 |
$737.57 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
175 |
152 |
$393.59 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
13 |
$176.56 |
| J2704 |
Injection, propofol, 10 mg |
328 |
194 |
$90.00 |
| 87581 |
|
14 |
13 |
$88.28 |
| 85027 |
|
32 |
27 |
$18.44 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
103 |
92 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
12 |
12 |
$0.00 |